Effects of Prednisone on a Patient with Dysferlinopathy Assessed by Maximal Voluntary Isometric Contraction: Alternate-Day Low-Dose Administration for a 17-Year Period
Glucocorticoids are candidates for the pharmacological treatment of dysferlinopathy. Deflazacort, however, showed a worse effect on muscle strength than placebo. Alternate-day low-dose prednisone may have beneficial effects with fewer adverse effects. The outcomes for a female patient with dysferlin...
Main Author: | Keiichi Takahashi |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2019-01-01
|
Series: | Case Reports in Neurology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/495746 |
Similar Items
-
THE CHALLENGING DIAGNOSIS OF DYSFERLINOPATHY – A CASE REPORT
by: Claudiu Gabriel Socoliuc, et al.
Published: (2021-06-01) -
Two cases with dysferlinopathy
by: Gaye Eryaşar, et al.
Published: (2011-03-01) -
Two cases with dysferlinopathy
by: Gaye Eryaşar, et al.
Published: (2011-03-01) -
Dysferlinopathy: Spectrum of pathological changes in skeletal muscle tissue
by: N Gayathri, et al.
Published: (2011-01-01) -
Incidental Severe Fatty Degeneration of the Erector Spinae in a Patient with L5–S1 Disc Extrusion Diagnosed with Limb-Girdle Muscular Dystrophy R2 Dysferin-related
by: Du Hwan Kim, et al.
Published: (2020-07-01)